Our mission is to provide the latest fertility treatments and to contribute to women’s lifelong health support as their primary physicians.

We have a wealth of experience in treating infertility due to ovarian insufficiency.
We treat a wide range of infertility patients using the latest treatment methods tailored to each patient’s specific needs.

Our clinic’s mission is to provide infertility treatment using the latest technology and support women’s lifelong health as their lifelong physicians.

The primary goal of our clinic is to treat a wide range of infertility patients by applying the expertise in intractable infertility treatment that we have cultivated over many years at university hospitals.

It used to be common knowledge that infertility treatment was impossible once a diagnosis of premature ovarian failure was made. At St. Marianna Medical School, I challenged this conventional wisdom and developed an ovulation induction method called the Rose Method, which has been used in patients diagnosed with premature ovarian insufficiency, and 37% of those who begin treatment under the age of 35 actually have a baby.

This treatment is very important today as the average age of patients undergoing fertility treatment continually increases and could be applied to many infertile patients over the age of 35 with normal ovarian function.

We aim to further improve these results by incorporating the latest technologies, such as in vitro activation (IVA), which is currently performed only at our clinic, and platelet-rich plasma (PRP) ovarian injection.

Another major goal of our clinic is the lifelong health care of women.

After the age of 50, all women suffer from estrogen deficiency. Estrogen is a type of female hormone that plays a variety of roles in maintaining external beauty, such as skin and hair, as well as maintaining bone mass and density in the body and preventing lifestyle-related diseases. The decrease in estrogen causes peculiar health problems in women. The most obvious examples are osteoporosis due to decreased bone mass and lifestyle-related diseases such as high blood pressure due to elevated cholesterol, which has a significant impact on women by reducing their quality of life (QOL) and shortening their healthy life expectancy. These problems can be resolved with proper estrogen replacement.

In patients with premature ovarian insufficiency, these estrogen deficiency-based problems are even more serious. We respond to these women’s health maintenance needs with measures centered on estrogen replacement. In a sense, this is an important mission that we have undertaken prior to infertility treatment.

Our clinic is staffed by myself, Dr. Masataka Furuya, Dr. Machiko Kimura, Dr. Motoki Ihara, and Dr. Yuka Tanaka, all of whom are experienced and knowledgeable doctors at the university hospital level. Our advisor, Professor Kazuhiro Kawamura of Juntendo University, works and collaborates with us to further improve the latest treatments such as IVA and PRP intra-ovarian injections, as well as to improve treatment results.

Doctors who were once involved in the development of treatments for premature ovarian insufficiency with me, such as staff from St. Marianna Medical College, also regularly see patients.

The staff at Rose Women's Clinic is committed to making the clinic even more useful for those suffering from infertility and general gynecological conditions.

Features of the Rose Women’s Clinic’s medical care： We treat premature ovarian insufficiency using the latest technology. Although several clinics around the world offer this service, we take the lead in providing full-scale infertility treatment for premature ovarian insufficiency.
We treat various stages of infertility using the minimum necessary methods. We provide women’s health care centered on hormone replacement therapy. We provide general gynecological care, uterine cancer and breast cancer screening, etc., led by female doctors.

Clinic Director Bunpei Ishizuka